2025-10-28 03:32:09
Latest Post
Mazagon Dock Shipbuilders Ltd declares interim dividend of Rs. 6
NTPC Green Energy Ltd Signs MoU with Paradip Port Authority to Explore Green Hydrogen Collaboration
Everest Industries Limited update on sale of land at Podanur to G Square
Hexaware Comments on Meritless Patent Lawsuit Filed by Natsoft
SAMHI receives MIDC Confirmation for an Extension to Develop Landmark Dual-Branded Hotel in Mumbai Metropolitan Region
Stock Report
IOL Chemicals and Pharmaceuticals Ltd receives EDQM Ceritificate of Suitability for Sitagliptin Phosphate Monohydrate
Posted On : 2025-10-28 00:36:09( TIMEZONE : IST )
IOL Chemicals and Pharmaceuticals Limited has announced that the European Directorate for the Quality of Medicines & Health Care (EDQM) has issued a Certificate of Suitability for Company's API product "Sitagliptin Phosphate Monohydrate" on 27th October 2025. Sitagliptin Phosphate Monohydrate is an oral antidiabetic medication used to control high blood sugar levels.
